Health care pharmaceutical companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Grifols has the lowest figure of the 50 health care pharmaceutical companies ranked by P/S ratio, at 0.7, followed by Viatris (1.6) and GSK (2.2). Figures as of 20 Nov 2026, 03:22 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 50
- Lowest
- Grifols0.7
- Median
- 6.7
- Combined market value
- SEK 50.56T
- Countries
- 10
- Not ranked
- 11no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | GrifolsGRFS · Health Care | 0.7 | SEK 56.9B | SEK 83.54 | 3.19% down | 0% up | ||
| 2 | ViatrisVTRS · Health Care | 1.6 | SEK 232.2B | SEK 202.54 | 1.97% down | 99% up | ||
| 3 | GSKGSK · Health Care | 2.2 | SEK 976.6B | SEK 487.20 | 1.56% down | 5% up | ||
| 4 | SanofiSNY · Health Care | 2.3 | SEK 1.13T | SEK 469.27 | 2.25% down | 4% down | ||
| 5 | Takeda PharmaceuticalTAK · Health Care | 2.4 | SEK 696.9B | SEK 218.13 | 0.66% up | 51% up | ||
| 6 | Amneal PharmaceuticalsAMRX · Health Care | 2.5 | SEK 75.9B | SEK 217.93 | 2.24% down | 90% up | ||
| 7 | Bristol-Myers SquibbBMY · Health Care | 2.5 | SEK 1.21T | SEK 594.38 | 2.05% down | 30% up | ||
| 8 | PfizerPFE · Health Care | 2.5 | SEK 1.6T | SEK 280.58 | 1.85% down | 15% up | ||
| 9 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.6 | SEK 458.2B | SEK 392.65 | 8.74% down | 74% up | ||
| 10 | Elanco Animal HealthELAN · Health Care | 2.8 | SEK 133.9B | SEK 267.85 | 1.54% down | 26% up | ||
| 11 | PTC TherapeuticsPTCT · Health Care | 2.8 | SEK 49.6B | SEK 594.23 | 3.16% down | 21% down | ||
| 12 | Legend BiotechLEGN · Health Care | 3.0 | SEK 31.8B | SEK 164.03 | 0.92% down | 41% down | ||
| 13 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.5 | SEK 126B | SEK 151.09 | 1.00% down | 8% up | ||
| 14 | ZoetisZTS · Health Care | 3.5 | SEK 334.4B | SEK 823.11 | 5.59% down | 26% down | ||
| 15 | Jazz PharmaceuticalsJAZZ · Health Care | 3.6 | SEK 154.6B | SEK 2,409.00 | 4.57% down | 41% up | ||
| 16 | BioMarin PharmaceuticalBMRN · Health Care | 3.7 | SEK 121.2B | SEK 625.76 | 0.02% down | 17% up | ||
| 17 | Novo NordiskNVO · Health Care | 3.7 | SEK 1.75T | SEK 396.02 | 1.42% down | 17% down | ||
| 18 | Abbott LaboratoriesABT · Health Care | 4.1 | SEK 1.83T | SEK 1,058.25 | 0.58% down | 16% down | ||
| 19 | AstraZenecaAZN · Health Care | 4.6 | SEK 2.77T | SEK 1,787.12 | 1.87% down | 1% up | ||
| 20 | Ionis PharmaceuticalsIONS · Health Care | 4.8 | SEK 46.2B | SEK 277.32 | 0.62% down | 63% down | ||
| 21 | Merck & CoMRK · Health Care | 5.0 | SEK 3.34T | SEK 1,353.10 | 3.61% down | 45% up | ||
| 22 | NovartisNVS · Health Care | 5.2 | SEK 2.91T | SEK 1,540.66 | 2.57% down | 25% up | ||
| 23 | AlkermesALKS · Health Care | 5.3 | SEK 79.1B | SEK 470.49 | 1.43% down | 66% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | 5.3 | SEK 201.7B | SEK 1,506.02 | 1.06% down | 66% down | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | 6.7 | SEK 973.2B | SEK 9,407.19 | 2.35% down | 28% up | ||
| 26 | Johnson & JohnsonJNJ · Health Care | 6.8 | SEK 6.55T | SEK 2,721.68 | 2.04% down | 34% up | ||
| 27 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | SEK 62.9B | SEK 444.72 | 1.25% up | 13% up | ||
| 28 | United TherapeuticsUTHR · Health Care | 7.5 | SEK 242.6B | SEK 5,696.23 | 3.16% down | 22% up | ||
| 29 | AbbVieABBV · Health Care | 8.2 | SEK 5.11T | SEK 2,888.77 | 0.86% down | 25% up | ||
| 30 | GenmabGMAB · Health Care | 8.5 | SEK 322.6B | SEK 523.17 | 0.75% up | 70% up | ||
| 31 | BeOne MedicinesONC · Health Care | 8.5 | SEK 465.2B | SEK 4,072.23 | 0.97% down | 16% up | ||
| 32 | Corcept TherapeuticsCORT · Health Care | 9.3 | SEK 72.5B | SEK 662.03 | 4.15% down | 10% down | ||
| 33 | Travere TherapeuticsTVTX · Health Care | 9.4 | SEK 47.2B | SEK 492.09 | 3.86% down | 45% up | ||
| 34 | Madrigal PharmaceuticalsMDGL · Health Care | 9.6 | SEK 93.9B | SEK 4,042.07 | 0.34% down | 27% down | ||
| 35 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 10.8 | SEK 74.9B | SEK 952.96 | 1.59% down | 129% up | ||
| 36 | Vertex PharmaceuticalsVRTX · Health Care | 11.0 | SEK 1.34T | SEK 5,304.60 | 2.94% down | 27% up | ||
| 37 | Axsome TherapeuticsAXSM · Health Care | 11.2 | SEK 72.7B | SEK 1,382.34 | 1.25% up | 6% down | ||
| 38 | Mirum PharmaceuticalsMIRM · Health Care | 12.0 | SEK 63.5B | SEK 973.08 | 3.27% up | 34% up | ||
| 39 | TG TherapeuticsTGTX · Health Care | 15.9 | SEK 99.9B | SEK 661.01 | 1.88% down | 117% up | ||
| 40 | Royalty PharmaRPRX · Health Care | 16.4 | SEK 396.7B | SEK 689.95 | 1.38% down | 79% up | ||
| 41 | Eli LillyLLY · Health Care | 18.5 | SEK 12.26T | SEK 13,765.51 | 2.29% down | 33% up | ||
| 42 | Ascendis PharmaASND · Health Care | 21.0 | SEK 171.1B | SEK 2,607.78 | 5.32% down | 29% up | ||
| 43 | Ligand PharmaceuticalsLGND · Health Care | 21.4 | SEK 58.5B | SEK 2,923.41 | 3.94% down | 50% up | ||
| 44 | BridgeBio PharmaBBIO · Health Care | 30.3 | SEK 155.2B | SEK 796.52 | 0.22% up | 21% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | 42.7 | SEK 82.5B | SEK 1,189.98 | 1.88% down | 18% up | ||
| 46 | InsmedINSM · Health Care | 52.3 | SEK 322.9B | SEK 1,471.79 | 20.58% up | 40% down | ||
| 47 | CytokineticsCYTK · Health Care | 81.4 | SEK 73B | SEK 524.29 | 0.27% up | 19% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | 176 | SEK 82.5B | SEK 1,263.54 | 2.47% down | 51% up | ||
| 49 | Dianthus TherapeuticsDNTH · Health Care | 2346 | SEK 48.7B | SEK 864.27 | 1.01% up | 108% up | ||
| 50 | Roivant SciencesROIV · Health Care | 3418 | SEK 287.6B | SEK 396.93 | 0.59% up | 91% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1882 SEK). 11 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies have the lowest P/S ratio?
Grifols (0.7), Viatris (1.6) and GSK (2.2) have the lowest P/S ratio of the 50 health care pharmaceutical companies ranked here as of 20 Nov 2026, 03:22 UTC.
How many health care pharmaceutical companies are in this ranking?
50 are ranked by P/S ratio. 11 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 50 health care pharmaceutical companies ranked by P/S ratio have a combined market value of SEK 50.56T as of 20 Nov 2026, 03:22 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care pharmaceutical companies by P/S ratio”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.